DK3445763T3 - UNKNOWN CRYSTALLIN SALTE FORMS OF 3- (1,2,4-TRIAZOLO [4,3-A] PYRIDIN-3-YLETHYNYL) -4-METHYL-N- (4 - ((4-METHYLPIPERAZIN-1-YL) METHYL) -3-TRIFLUOROMETHYLPHENYL) BENZAMIDE FOR MEDICAL USE - Google Patents

UNKNOWN CRYSTALLIN SALTE FORMS OF 3- (1,2,4-TRIAZOLO [4,3-A] PYRIDIN-3-YLETHYNYL) -4-METHYL-N- (4 - ((4-METHYLPIPERAZIN-1-YL) METHYL) -3-TRIFLUOROMETHYLPHENYL) BENZAMIDE FOR MEDICAL USE Download PDF

Info

Publication number
DK3445763T3
DK3445763T3 DK17786237.2T DK17786237T DK3445763T3 DK 3445763 T3 DK3445763 T3 DK 3445763T3 DK 17786237 T DK17786237 T DK 17786237T DK 3445763 T3 DK3445763 T3 DK 3445763T3
Authority
DK
Denmark
Prior art keywords
methyl
salte
ylethynyl
crystallin
methylpiperazin
Prior art date
Application number
DK17786237.2T
Other languages
Danish (da)
Inventor
Germes Grigorievich Chilov
Ilya Yurievich Titov
Original Assignee
Llc «Fusion Pharma»
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Llc «Fusion Pharma» filed Critical Llc «Fusion Pharma»
Application granted granted Critical
Publication of DK3445763T3 publication Critical patent/DK3445763T3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK17786237.2T 2016-04-18 2017-04-18 UNKNOWN CRYSTALLIN SALTE FORMS OF 3- (1,2,4-TRIAZOLO [4,3-A] PYRIDIN-3-YLETHYNYL) -4-METHYL-N- (4 - ((4-METHYLPIPERAZIN-1-YL) METHYL) -3-TRIFLUOROMETHYLPHENYL) BENZAMIDE FOR MEDICAL USE DK3445763T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
RU2016114904A RU2652992C2 (en) 2016-04-18 2016-04-18 Novel crystalline salt form 3-(1,2,4-triazolo[4,3-a]pyridin-3-ylethynyl)-4-methyl-n-(4-((4-methylpiperazin-1-yl)methyl)-3-trifluoromethylphenyl) benzamide for medical application
PCT/RU2017/050025 WO2017184032A1 (en) 2016-04-18 2017-04-18 Novel crystalline salt forms of 3-(1,2,4-triazolo[4,3-a]pyridine-3-ylethynyl)-4-methyl-n-(4-((4-methylpiperazin-1-yl)methyl)-3-trifluoromethylphenyl)benzamide for medical application

Publications (1)

Publication Number Publication Date
DK3445763T3 true DK3445763T3 (en) 2022-01-31

Family

ID=60116178

Family Applications (1)

Application Number Title Priority Date Filing Date
DK17786237.2T DK3445763T3 (en) 2016-04-18 2017-04-18 UNKNOWN CRYSTALLIN SALTE FORMS OF 3- (1,2,4-TRIAZOLO [4,3-A] PYRIDIN-3-YLETHYNYL) -4-METHYL-N- (4 - ((4-METHYLPIPERAZIN-1-YL) METHYL) -3-TRIFLUOROMETHYLPHENYL) BENZAMIDE FOR MEDICAL USE

Country Status (17)

Country Link
US (1) US11225474B2 (en)
EP (1) EP3445763B1 (en)
JP (1) JP6463874B2 (en)
KR (1) KR101929725B1 (en)
CN (1) CN108473492B (en)
AU (1) AU2017254345A1 (en)
BR (1) BR112018071498A2 (en)
CA (1) CA3021306C (en)
DK (1) DK3445763T3 (en)
EA (1) EA032865B1 (en)
ES (1) ES2906048T3 (en)
HK (1) HK1254731A1 (en)
IL (1) IL262368A (en)
PL (1) PL3445763T3 (en)
RU (1) RU2652992C2 (en)
UA (1) UA124627C2 (en)
WO (1) WO2017184032A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2652992C2 (en) 2016-04-18 2018-05-04 Общество С Ограниченной Ответственностью "Фьюжн Фарма" Novel crystalline salt form 3-(1,2,4-triazolo[4,3-a]pyridin-3-ylethynyl)-4-methyl-n-(4-((4-methylpiperazin-1-yl)methyl)-3-trifluoromethylphenyl) benzamide for medical application
RU2664420C1 (en) * 2017-10-31 2018-08-17 Общество С Ограниченной Ответственностью "Фьюжн Фарма" Pharmaceutical composition, dosage and method of treatment ph+ leukemia
CN112505131B (en) * 2020-11-11 2023-01-13 山东省计量科学研究院 Quantitative value and quantity value tracing method of methyl arsenic solution standard substance

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101885722B (en) * 2010-07-01 2013-07-24 中国科学院广州生物医药与健康研究院 Heterocycle alkyne and benzene compound, medicinal composition and application thereof
RU2477772C2 (en) 2011-05-20 2013-03-20 Государственное образовательное учреждение высшего профессионального образования "Саратовский государственный технический университет" Device for trenchless laying of pipelines by piercing method
RU2477723C2 (en) * 2011-06-16 2013-03-20 Общество С Ограниченной Ответственностью "Фьюжн Фарма" Protein kinase inhibitor (versions), use thereof for treating oncological diseases and based pharmaceutical composition
WO2013170770A1 (en) * 2012-05-16 2013-11-21 上海医药集团股份有限公司 Acetylene derivatives having antitumor activity
CN103848829B (en) * 2012-11-28 2017-04-12 南京圣和药业股份有限公司 Heteroaryl alkyne compounds and application thereof
GB2522226A (en) * 2014-01-17 2015-07-22 Agency Science Tech & Res Heteroaryl alkyne derivatives and uses thereof
CN104250253B (en) * 2014-09-12 2017-04-05 辽宁大学 Substituted-tetrahydro naphthoyl aminated compounds and its pharmaceutically acceptable salt and preparation method and application
RU2652992C2 (en) 2016-04-18 2018-05-04 Общество С Ограниченной Ответственностью "Фьюжн Фарма" Novel crystalline salt form 3-(1,2,4-triazolo[4,3-a]pyridin-3-ylethynyl)-4-methyl-n-(4-((4-methylpiperazin-1-yl)methyl)-3-trifluoromethylphenyl) benzamide for medical application

Also Published As

Publication number Publication date
PL3445763T3 (en) 2022-02-28
CA3021306A1 (en) 2017-10-26
UA124627C2 (en) 2021-10-20
JP2018530598A (en) 2018-10-18
EA032865B1 (en) 2019-07-31
US20200325131A1 (en) 2020-10-15
RU2016114904A (en) 2017-10-23
ES2906048T3 (en) 2022-04-13
WO2017184032A1 (en) 2017-10-26
EA201600487A1 (en) 2017-10-31
RU2652992C2 (en) 2018-05-04
JP6463874B2 (en) 2019-02-06
HK1254731A1 (en) 2019-07-26
KR101929725B1 (en) 2018-12-14
BR112018071498A2 (en) 2019-02-19
US11225474B2 (en) 2022-01-18
CN108473492A (en) 2018-08-31
EP3445763A4 (en) 2019-12-04
EP3445763B1 (en) 2021-11-10
EP3445763A1 (en) 2019-02-27
AU2017254345A1 (en) 2018-11-22
CN108473492B (en) 2020-01-07
IL262368A (en) 2018-11-29
KR20180037289A (en) 2018-04-11
CA3021306C (en) 2023-05-16

Similar Documents

Publication Publication Date Title
DK3134386T3 (en) ISOINDOLIN-1-ON DERIVATIVES WITH CHOLINERG MUSCARIN-M1 RECEPTOR-POSITIVE ALLOSTERIC MODULATOR ACTIVITY FOR THE TREATMENT OF ALZHEIMER'S DISEASE
CY1121071T1 (en) NAPTHYRIDINE PRODUCTS AS INTEGRIN ALPHA V ALBONE V BETA 6 COMPETITORS FOR THERAPY BC FIBROID DISEASES
DK3800189T3 (en) PREPARATION OF (S)-N-(5-((R)-2-(2,5-DIFLUORPHENYL)PYRROLIDIN-1-YL)PYRAZOLO[1,5-A]PYRIMIDIN-3-YL)-3-HYDROXYPYRROLIDIN- 1-CARBOXAMIDE
DK3319215T3 (en) HEARING INSTRUMENT INCLUDING SWITCHED CAPACITOR DC-DC POWER SUPPLY
CL2021003372A1 (en) Benzisoxazole sulfonamide derivatives
DK3672975T3 (en) FUSED HETEROCYCLIC DERIVATIVES AS BCL-2 INHIBITORS FOR THE TREATMENT OF NEOPLASTIC DISEASES
MA52623A (en) SUBSTITUTED DIHYDROPYRAZOLO PYRAZINE CARBOXAMIDE DERIVATIVES
DK3445763T3 (en) UNKNOWN CRYSTALLIN SALTE FORMS OF 3- (1,2,4-TRIAZOLO [4,3-A] PYRIDIN-3-YLETHYNYL) -4-METHYL-N- (4 - ((4-METHYLPIPERAZIN-1-YL) METHYL) -3-TRIFLUOROMETHYLPHENYL) BENZAMIDE FOR MEDICAL USE
GB201609519D0 (en) Polymorphs of n-[(2,6-difluoro-3-methoxyphenyl)methyl]-3-(methoxymethyl)-1-({4-[(2-oxopyr idin-1-yl)methyl]phenyl}methyl)pyrazole-4-carboxamide
IL254132B (en) Solid preparation of n-(4-(1-(2,6-difluorobenzyl)-5-((dimethylamino)methyl)-3-(6-methoxy-3-pyridazinyl)-2,4-dioxo-1,2,3,4-tetrahydrothieno[2,3-d]pyrimidin-6-yl)phenyl)-n’-methoxyurea or a salt thereof
TR201909353T4 (en) Multiple sclerosis treatment.
DK3526207T3 (en) HETEROCYCLIC COMPOUNDS WITH ACTIVITY AS MODULATORS OF MUSCARINE M1 AND / OR M4 RECEPTORS IN THE TREATMENT OF CNS DISEASES AND PAIN
DK3296299T3 (en) CRYSTAL FORM OF 3-ETHYL-4- {3-ISOPROPYL-4- (4- (1-METHYL-1H-PYRAZOL-4-YL) -1H-IMIDAZOL-1-YL) -1H-PYRAZOLO [3,4-B ] pyridin-1-yl} benzamide
DK3749308T3 (en) TREATMENT OF PATIENTS WITH CLASSIC FABRY'S DISEASE WITH MIGALASTAT
HUE063879T2 (en) 4-(1,3,4-oxadiazole-2-yl)pyridine-2(1h)-one derivatives as histone deacetylase 6 (hdac6) inhibitors for the treatment of e.g. infections
DK3529234T3 (en) COMPOUNDS, METHOD FOR OBTAINING THE COMPOUNDS, PHARMACEUTICAL COMPOSITION, USE OF THE COMPOUNDS AND METHOD FOR THE TREATMENT OF PSYCHIATRIC DISORDERS AND/OR SLEEP DISORDERS
DK3452465T3 (en) SUBSTITUTED 2,4-DIAMINOQUINOLINE DERIVATIVES FOR USE IN THE TREATMENT OF PROLIFERATIVE DISEASES
BR112018002140A2 (en) USE OF MOLECULAR MARKERS IL-3, IL-33 and IL-12p40 TO CHARACTERIZE RESPIRATORY INFECTIONS BY SINCITIAL RESPIRATORY VIRUS AND HUMAN METAPNEUMOVIRUS
DK3624795T3 (en) Condensed, heteroaromatic aniline compounds for the treatment of skin disorders
DK3585327T3 (en) SYSTEM FOR THE TREATMENT OF SLEEP DISTURBED BREATH
BR112018012095A2 (en) solid forms of substituted 5,6-dihydro-6-phenylbenzo [f] isoquinolin-2-amine compounds
DK3416654T3 (en) MEDICAL USE OF 5'-ADENOSINDIPHOSPHATRIBOSE (ADPR)
IT201700031928A1 (en) PERFECTED BOTTAL FOR THE TREATMENT OF BOTTALING OF THE SKINS
DK3853219T3 (en) HERBICIDELY ACTIVE SUBSTITUTED PHENYL PYRIMIDINE HYDRAZIDES
DK3834788T3 (en) DISPOSABLE DIAPER FOR ADULTS